Literature DB >> 18482106

Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients.

Bernd Feige1, Anam Al-Shajlawi, Christoph Nissen, Ulrich Voderholzer, Magdolna Hornyak, Kai Spiegelhalder, Corinna Kloepfer, Michael Perlis, Dieter Riemann.   

Abstract

Primary insomnia (PI) is characterized by low subjective sleep quality which cannot always be verified using polysomnography (PSG). To shed light on this discrepancy, subjective estimates of sleep and PSG variables were compared in patients with PI and good sleeper controls (GSC). 100 patients with PI (age: 42.57 +/- 12.50 years, medication free for at least 14 days) and 100 GSC (41.12 +/- 13.99 years) with a sex distribution of 46 men and 54 women in each group were included. Both PSG and questionnaire variables showed clear impairments of sleep quality in PI compared with GSC. The arousal index within total sleep time was increased, which was mainly because of a strong increase within rapid eye movement (REM) sleep. Subjectively, more PI than GSC subjects estimated wake times longer than obtained from PSG. Linear modeling analysis of subjective wake time in terms of PSG parameters revealed that in addition to PSG defined wake time, REM sleep time contributed significantly to subjective wake time. This REM sleep contribution was larger for PI than for GSC subjects. The findings suggest that REM sleep-related processes might contribute to subjectively disturbed sleep and the perception of waking time in patients with PI.

Entities:  

Mesh:

Year:  2008        PMID: 18482106     DOI: 10.1111/j.1365-2869.2008.00651.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  60 in total

1.  Insomnia research is coming of age.

Authors:  Dieter Riemann
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

2.  Sleep misperception and chronic insomnia in the general population: role of objective sleep duration and psychological profiles.

Authors:  Julio Fernandez-Mendoza; Susan L Calhoun; Edward O Bixler; Maria Karataraki; Duanping Liao; Antonio Vela-Bueno; María Jose Ramos-Platon; Katherine A Sauder; Maria Basta; Alexandros N Vgontzas
Journal:  Psychosom Med       Date:  2010-10-26       Impact factor: 4.312

3.  Insomnia with Short Sleep Duration: Nosological, Diagnostic, and Treatment Implications.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza
Journal:  Sleep Med Clin       Date:  2013-09-01

Review 4.  The impact of stress on sleep: Pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders.

Authors:  David A Kalmbach; Jason R Anderson; Christopher L Drake
Journal:  J Sleep Res       Date:  2018-05-24       Impact factor: 3.981

5.  [Portable sleep monitoring in patients with disorders in falling asleep or maintaining sleep].

Authors:  I Fietze; K Nötzel; A Blau; M Glos; T Penzel
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

Review 6.  The pathophysiology of insomnia.

Authors:  Jessica C Levenson; Daniel B Kay; Daniel J Buysse
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

7.  Is insomnia a breathing disorder?

Authors:  Wilfred R Pigeon; Michael J Sateia
Journal:  Sleep       Date:  2012-12-01       Impact factor: 5.849

Review 8.  Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2013-02-16       Impact factor: 11.609

9.  [Disturbances of slow-wave sleep and psychiatric disorders].

Authors:  J P Doerr; V Hirscher; D Riemann; U Voderholzer
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

10.  Sleep Misperception in Chronic Insomnia Patients with Obstructive Sleep Apnea Syndrome: Implications for Clinical Assessment.

Authors:  Su Jung Choi; Sooyeon Suh; Jason Ong; Eun Yeon Joo
Journal:  J Clin Sleep Med       Date:  2016-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.